[1] |
UN Department of Economic and Social Affairs, Population Division. World population ageing 2019[EB/OL]. New York, NY: United Nations, 2020. https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Report.pdf.
|
[2] |
WHO. China country assessment report on ageing and health[EB/OL]. 2015. https://apps.who.int/iris/handle/10665/194271.
|
[3] |
Ren J, Sowers JR, Zhang Y. Metabolic stress, autophagy, and cardiovascular aging: from pathophysiology to therapeutics[J]. Trends Endocrinol Metab, 2018, 29(10): 699-711.
doi: 10.1016/j.tem.2018.08.001
URL
|
[4] |
张洁, 陈友鹏, 李虹, 等. 中老年新发脂肪肝与糖脂代谢指标增量变化的关系[J]. 中国老年学杂志, 2012, 32(11): 2346-2347.
|
[5] |
Finkel T. The metabolic regulation of aging[J]. Nat Med, 2015, 21(12): 1416-1423.
doi: 10.1038/nm.3998
pmid: 26646498
|
[6] |
Edwards BK, Noone AM, Mariotto AB, et al. Annual Report to the Nation on the Status of Cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer[J]. Cancer, 2014, 120(9): 1290-1314.
doi: 10.1002/cncr.28509
pmid: 24343171
|
[7] |
Davis JW, Chung R, Juarez DT. Prevalence of comorbid conditions with aging among patients with diabetes and cardiovascular disease[J]. Hawaii Med J, 2011, 70(10): 209-213.
pmid: 22162595
|
[8] |
Zhang L, Ma L, Sun F, et al. A Multicenter study of multimorbidity in older adult inpatients in china[J]. J Nutr Health Aging, 2020, 24(3): 269-276.
doi: 10.1007/s12603-020-1311-x
pmid: 32115607
|
[9] |
张冉, 路云, 张闪闪, 等. 中国老年人慢性病共病患病模式及疾病相关性分析[J]. 中国公共卫生, 2019, 35(08): 1003-1005.
|
[10] |
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1223-1249.
doi: 10.1016/S0140-6736(20)30752-2
pmid: 33069327
|
[11] |
Niccoli T, Partridge L. Ageing as a risk factor for disease[J]. Curr Biol, 2012, 22(17): R741-R752.
doi: 10.1016/j.cub.2012.07.024
URL
|
[12] |
World Health Organization. World Health Organization China country assessment report on ageing and health[EB/OL]. 2015. https://apps.who.int/iris/handle/10665/194271.
|
[13] |
Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy[J]. Hypertension, 1995, 26(6 Pt 1):869-879.
doi: 10.1161/01.hyp.26.6.869
pmid: 7490142
|
[14] |
Palta P, Albert MS, Gottesman RF. Heart health meets cognitive health: evidence on the role of blood pressure[J]. Lancet Neurol, 2021, 20(10): 854-867.
doi: 10.1016/S1474-4422(21)00248-9
pmid: 34536406
|
[15] |
Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2017 focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk[J]. J Am Coll Cardiol, 2017, 70(14): 1785-1822.
doi: S0735-1097(17)38898-8
pmid: 28886926
|
[16] |
Halter JB, Musi N, McFarland Horne F, et al. Diabetes and cardiovascular disease in older adults: current status and future directions[J]. Diabetes, 2014, 63(8): 2578-2589.
doi: 10.2337/db14-0020
pmid: 25060886
|
[17] |
Wang T, Zhao Z, Wang G, et al. Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study[J]. The Lancet Healthy Longevity, 2021, 2(10): e618-e628.
doi: 10.1016/S2666-7568(21)00177-X
URL
|
[18] |
Wang T, Zhao Z, Yu X, et al. Age-specific modifiable risk factor profiles for cardiovascular disease and all-cause mortality: a nationwide, population-based, prospective cohort study[J]. The Lancet Regional Health-Western Pacific, 2021, 17: 100277.
doi: 10.1016/j.lanwpc.2021.100277
URL
|